Literature DB >> 6151120

[A biochemical theory of schizophrenia].

H H Kornhuber, J Kornhuber, J S Kim, M E Kornhuber.   

Abstract

In addition to the dopamine hypothesis, a glutamate hypothesis has been recently discussed in the biochemical theories on the cause of schizophrenia. In schizophrenic patients less glutamic acid has been found in the cerebrospinal fluid. Glutamate is probably the most important excitatory transmitter of the mammalian forebrain. The liberation of glutamic acid in the striatum is inhibited by dopamine, more specifically by the D2 receptor, which is also though to be responsible for the antipsychotic effects of neuroleptic drugs. It seems possible that schizophrenia may be primarily caused by underfunction of glutamatergic corticostriatal and corticomesolimbic neurons rather than by overfunction of the dopaminergic system. The negative cognitive symptoms associated with schizophrenia would fit in with this hypothesis. The classical and the new atypical neuroleptic drugs show differential effects on glutamate and GABA in the brain tissue of the striatum and in the cerebrospinal fluid. Whereas sulpiride diminishes glutamate in the striatum and enhances glutamate in the cerebrospinal fluid, tiapride does not affect either of them. Correspondingly, tiapride does not show any antipsychotic effects. Haloperidol, on the other hand, enhances the GABA level in the striatum in a dose-related manner. These findings may perhaps prompt experimental research to find antipsychotic drugs with fewer side effects.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6151120

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  6 in total

1.  Effects of the novel NMDA-receptor antagonist SDZ EAA 494 on memory and attention in humans.

Authors:  S Rockstroh; M Emre; A Tarral; R Pokorny
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

2.  The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice.

Authors:  M Carlsson; A Carlsson
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

3.  [3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients.

Authors:  J Kornhuber; F Mack-Burkhardt; P Riederer; G F Hebenstreit; G P Reynolds; H B Andrews; H Beckmann
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

4.  Relationships between clinical effects and monoamine metabolites and amino acids in sulpiride-treated schizophrenic patients.

Authors:  G Alfredsson; F A Wiesel
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Evidence for biochemical heterogeneity in schizophrenia: a multivariate study of monoaminergic indices in human post-mortal brain tissue.

Authors:  L O Hansson; N Waters; B Winblad; C G Gottfries; A Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1994

6.  GRIN3B missense mutation as an inherited risk factor for schizophrenia: whole-exome sequencing in a family with a familiar history of psychotic disorders.

Authors:  Tobias Hornig; Björn Grüning; Kousik Kundu; Torsten Houwaart; Rolf Backofen; Knut Biber; Claus Normann
Journal:  Genet Res (Camb)       Date:  2017-01-30       Impact factor: 1.588

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.